Guilderland, NY, United States of America

Mahender Gurram



 

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: The Innovative Mind of Mahender Gurram

Introduction

Mahender Gurram is an accomplished inventor based in Guilderland, NY, with a remarkable focus on pharmaceutical innovations. His dedication to studying and developing compounds has led to significant advancements in the treatment of diseases, particularly those related to cancer.

Latest Patents

Gurram holds two patents, showcasing his expertise in the creation of tricyclic compounds. His most recent patents revolve around "Tricyclic compounds and PBK inhibitors containing the same." These innovative compounds serve as PBK inhibitors and are designed to treat PBK-related diseases, including cancer. The importance of these compounds underscores Gurram's commitment to addressing critical health challenges through scientific research.

Career Highlights

Currently, Mahender Gurram is an integral part of Oncotherapy Science, Incorporated, where he contributes his vast knowledge and expertise to the development of groundbreaking therapies. His work at the company plays a crucial role in the pursuit of effective cancer treatments, marking significant progress in the field of oncology.

Collaborations

Gurram collaborates with distinguished colleagues such as Yusuke Nakamura and Yo Matsuo, with whom he shares common goals and visions for advancing healthcare innovations. Their collective efforts highlight the importance of teamwork in the advancement of patentable inventions and the development of impactful therapies.

Conclusion

Mahender Gurram's contributions to science through his patents and collaborative efforts at Oncotherapy Science, Incorporated, reflect his innovative spirit and commitment to improving patient outcomes. His work continues to inspire the next generation of inventors and researchers within the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…